IL145569A0 - Compositions for improving fertility - Google Patents

Compositions for improving fertility

Info

Publication number
IL145569A0
IL145569A0 IL14556900A IL14556900A IL145569A0 IL 145569 A0 IL145569 A0 IL 145569A0 IL 14556900 A IL14556900 A IL 14556900A IL 14556900 A IL14556900 A IL 14556900A IL 145569 A0 IL145569 A0 IL 145569A0
Authority
IL
Israel
Prior art keywords
compositions
improving fertility
fertility
improving
Prior art date
Application number
IL14556900A
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL145569A0 publication Critical patent/IL145569A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL14556900A 1999-03-23 2000-03-21 Compositions for improving fertility IL145569A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9906714.2A GB9906714D0 (en) 1999-03-23 1999-03-23 Compositions for improving fertility
PCT/IB2000/000382 WO2000056296A2 (en) 1999-03-23 2000-03-21 Compositions for improving fertility

Publications (1)

Publication Number Publication Date
IL145569A0 true IL145569A0 (en) 2002-06-30

Family

ID=10850229

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14556900A IL145569A0 (en) 1999-03-23 2000-03-21 Compositions for improving fertility

Country Status (29)

Country Link
US (1) US7115650B1 (es)
EP (1) EP1162969B1 (es)
JP (1) JP2002539243A (es)
KR (1) KR100689951B1 (es)
CN (1) CN1196483C (es)
AR (1) AR023129A1 (es)
AT (1) ATE328594T1 (es)
AU (1) AU765912B2 (es)
CA (1) CA2366911C (es)
CZ (1) CZ20013410A3 (es)
DE (1) DE60028552T2 (es)
DK (1) DK1162969T3 (es)
ES (1) ES2265918T3 (es)
GB (1) GB9906714D0 (es)
HK (1) HK1046647B (es)
HU (1) HUP0200410A3 (es)
IL (1) IL145569A0 (es)
MX (1) MXPA01009612A (es)
MY (1) MY135683A (es)
NO (1) NO20014607L (es)
NZ (1) NZ514449A (es)
PL (1) PL195779B1 (es)
PT (1) PT1162969E (es)
RU (1) RU2246944C2 (es)
TR (1) TR200102647T2 (es)
TW (1) TWI244920B (es)
UA (1) UA77644C2 (es)
WO (1) WO2000056296A2 (es)
ZA (1) ZA200108083B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
GB9928330D0 (en) 1999-11-30 2000-01-26 Ferring Bv Novel antidiabetic agents
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
GB0109146D0 (en) * 2001-04-11 2001-05-30 Ferring Bv Treatment of type 2 diabetes
ATE370943T1 (de) 2001-06-27 2007-09-15 Smithkline Beecham Corp Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
ATE374181T1 (de) 2001-06-27 2007-10-15 Smithkline Beecham Corp Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren
EP1399420B1 (en) 2001-06-27 2007-12-05 SmithKline Beecham Corporation Pyrrolidines as dipeptidyl peptidase inhibitors
US7074798B2 (en) 2002-02-25 2006-07-11 Eisai Co., Ltd Xanthine derivative and DPPIV inhibitor
US6710040B1 (en) 2002-06-04 2004-03-23 Pfizer Inc. Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
CN100469778C (zh) 2002-06-06 2009-03-18 卫材R&D管理有限公司 新的稠合咪唑衍生物
WO2005026114A1 (en) * 2003-09-17 2005-03-24 Pfizer Inc. Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
DK1942898T4 (da) 2005-09-14 2014-06-02 Takeda Pharmaceutical Dipeptidylpeptidase-inhibitorer til behandling af diabetes
KR101368988B1 (ko) 2005-09-16 2014-02-28 다케다 야쿠힌 고교 가부시키가이샤 디펩티딜 펩티다제 억제제
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
AU2011237775A1 (en) 2010-04-06 2012-11-22 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
CN103539791B (zh) 2010-09-22 2017-01-11 艾尼纳制药公司 Gpr119 受体调节剂和对与其相关的障碍的治疗
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
AU2016229982B2 (en) 2015-03-09 2020-06-18 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
EP3509604A4 (en) * 2016-09-07 2020-08-26 Trustees of Tufts College POLYTHERAPIES USING IMMUNO-DASH INHIBITORS AND PGE2 ANTAGONISTS
BR112019020485A2 (pt) 2017-04-03 2020-05-12 Coherus Biosciences, Inc. Agonista ppary para tratamento de paralisia supranuclear progressiva

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016339A1 (en) 1990-04-14 1991-10-31 New England Medical Center Hospitals, Inc. Inhibitors of dipeptidyl-aminopeptidase type iv
ATE349461T1 (de) * 1991-10-22 2007-01-15 New England Medical Center Inc Inhibitoren der dipeptidyl-aminopeptidase vom typ iv
IL111785A0 (en) * 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US5952301A (en) 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function

Also Published As

Publication number Publication date
EP1162969B1 (en) 2006-06-07
MXPA01009612A (es) 2002-07-02
CA2366911A1 (en) 2000-09-28
JP2002539243A (ja) 2002-11-19
RU2246944C2 (ru) 2005-02-27
TR200102647T2 (tr) 2002-01-21
AU765912B2 (en) 2003-10-02
PL350797A1 (en) 2003-02-10
TWI244920B (en) 2005-12-11
MY135683A (en) 2008-06-30
WO2000056296A3 (en) 2001-01-25
PL195779B1 (pl) 2007-10-31
HUP0200410A2 (en) 2002-08-28
NZ514449A (en) 2002-11-26
AU3317700A (en) 2000-10-09
HK1046647B (zh) 2005-09-30
UA77644C2 (en) 2007-01-15
HUP0200410A3 (en) 2002-09-30
NO20014607L (no) 2001-11-20
DE60028552D1 (de) 2006-07-20
WO2000056296A2 (en) 2000-09-28
PT1162969E (pt) 2006-10-31
EP1162969A2 (en) 2001-12-19
KR20010108388A (ko) 2001-12-07
US7115650B1 (en) 2006-10-03
NO20014607D0 (no) 2001-09-21
ES2265918T3 (es) 2007-03-01
DE60028552T2 (de) 2007-06-28
CZ20013410A3 (cs) 2002-04-17
AR023129A1 (es) 2002-09-04
CN1352557A (zh) 2002-06-05
GB9906714D0 (en) 1999-05-19
ATE328594T1 (de) 2006-06-15
KR100689951B1 (ko) 2007-03-08
ZA200108083B (en) 2002-11-27
HK1046647A1 (en) 2003-01-24
CA2366911C (en) 2010-01-19
CN1196483C (zh) 2005-04-13
DK1162969T3 (da) 2006-09-18

Similar Documents

Publication Publication Date Title
PL350797A1 (en) Compositions for improving fertility
GB9918180D0 (en) Novel compositions
GB9921037D0 (en) Compositions
EP1145707A4 (en) COMPOSITIONS FOR OUTSIDE USE
GB9904049D0 (en) Rapidly-soluble compositions
EP1208845A4 (en) COMPOSITIONS FOR TREATING HYPOFERTILITY
GB9902520D0 (en) Composition
AP2001002273A0 (en) Rescorcinol composition
GB2366984B (en) Composition
GB9914446D0 (en) Composition
GB9929622D0 (en) Compositions
GB9904931D0 (en) Compositions
GB9903924D0 (en) Cosmectic compositions
GB9926833D0 (en) Compositions
GB2357714B (en) Composition
GB9920672D0 (en) Gasoline compositions
GB9914582D0 (en) Composition
GB9926243D0 (en) Compositions
GB9912423D0 (en) Compositions
GB9905572D0 (en) Compositions
GB9912422D0 (en) Compositions
GB9904057D0 (en) Compositions
GB9912421D0 (en) Compositions
GB9912420D0 (en) Compositions
GB9905571D0 (en) Compositions